ShorrAF.Review of studies of the impact on gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med. 2009;37:1463-1469.
2.
HyleEPLipworthADZaoutisTENachamkinIBilkerWBLautenbachE.Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med. 2005;165:1375-1380.
3.
KollefMHShermanGWardSFraserVJ.Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-474.
4.
Garnacho-MonteroJGarcia-GarmendiaJLBarrero-AlmodovarAJimenez-JimenezFJPerez-ParedesCOrtiz-LeybaC.Impact of adequate empiric antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742-2751.
5.
CosgroveSE.The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42:S82-S89.
6.
SievertDMRicksPEdwardsJR, et al. Antimicrobial resistant pathogens associated with health care-associated infections: summary of data reported to the national health care safety network at the centers for disease control and prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34:1-14.
7.
SmithRCoastJ.The true cost of antimicrobial resistance. BMJ. 2013;346:F1493.
8.
ZilberbergMDNathansonBHSulhamKFanWShorrAF.Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infect Dis. 2017;17:279.
